Lexaria Bioscience Corp.
LEXX
$0.62
$0.000.36%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.50% | -69.99% | -45.62% | 36.50% | 300.58% |
| Total Receivables | -66.60% | 138.45% | 71.83% | -7.25% | -50.72% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 91.53% | -4.66% | 116.94% | 218.74% | 235.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -39.23% | -56.09% | -36.14% | 42.60% | 227.65% |
|
|
|||||
| Total Current Assets | -39.23% | -56.09% | -36.14% | 42.60% | 227.65% |
| Net Property, Plant & Equipment | -20.82% | -14.04% | -2.32% | 1.78% | 2.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -39.04% | -40.43% | 3.51% | -2.52% | 2.22% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.63% | 0.63% | 62.03% | 31.69% |
| Total Assets | -38.22% | -52.92% | -32.71% | 36.61% | 170.04% |
|
|
|||||
| Total Accounts Payable | 348.87% | 49.99% | 392.58% | 2,580.71% | 184.58% |
| Total Accrued Expenses | 3,508.70% | 30.12% | 11,377.33% | 6,580.52% | 1.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.99% | 8.57% | 9.52% | 10.98% | 12.50% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 389.09% | 35.85% | 853.91% | 2,130.60% | 139.20% |
|
|
|||||
| Total Current Liabilities | 389.09% | 35.85% | 853.91% | 2,130.60% | 139.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.52% | -27.81% | -24.80% | -22.94% | -21.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 282.14% | 30.09% | 480.25% | 838.69% | 57.36% |
|
|
|||||
| Common Stock & APIC | 9.34% | 11.58% | 11.56% | 18.67% | 26.40% |
| Retained Earnings | -19.89% | -23.08% | -23.07% | -19.72% | -15.59% |
| Treasury Stock & Other | -230.87% | -255.05% | -270.32% | -473.79% | -622.73% |
| Total Common Equity | -49.74% | -62.80% | -45.15% | 9.57% | 161.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -49.74% | -62.80% | -45.15% | 9.57% | 161.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.39% | -2.54% | -2.66% | -2.98% | -2.84% |
| Total Equity | -51.85% | -66.02% | -46.99% | 9.97% | 178.53% |
|
|
|||||